LOS ANGELES, Dec. 19, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (AADI) today announced it has entered into an exclusive license agreement for development and global commercialization of a three-asset ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback